Quoin Pharmaceuticals reported cash from operations of -$3.14M and free cash flow of -$3.14M for the quarter ended Jun 2026, up 14.7% year over year. This cash flow statement covers 22 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2020 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||
| Share-based Compensation | 0.01M | 3.74M | 3.37M | 0.27M | 10.37M | 0.86M | 0.86M | 0.30M | 10.24M | 10.06M | 8.99M | 0.33M | 1.11M | 1.11M | 2.50M | 0.29M | 7.30M | 6.80M | ||||
| Gains from Investment Securities | -0.15M | 8.26M | -0.08M | |||||||||||||||||||
| Cash from Operations | -0.91M | -3.18M | -2.09M | -2.15M | -2.29M | -1.94M | -1.75M | -1.57M | -1.32M | -3.22M | -1.43M | -2.01M | -2.18M | -2.24M | -2.59M | -3.69M | -2.23M | -5.04M | -4.87M | -3.14M | ||
| Change in Working Capital | ||||||||||||||||||||||
| Change in Accured Expenses | 0.19M | 0.89M | 0.16M | 0.28M | -0.59M | -0.07M | 0.58M | 0.18M | 0.29M | -1.00M | 0.64M | -0.27M | -0.48M | 0.38M | 0.67M | -0.52M | 1.43M | -0.26M | -0.20M | 1.27M | ||
| Investing Activities | ||||||||||||||||||||||
| Change in Acquisitions & Divestments | 10.00M | 3.04M | 4.60M | 2.64M | 5.18M | 3.15M | 4.21M | 2.82M | 2.77M | 1.68M | 2.54M | 1.00M | 5.10M | 5.00M | ||||||||
| Cash from Investing Activities | -0.11M | -0.25M | -0.05M | -0.20M | -9.90M | -3.49M | 3.04M | 821.00 | 2.64M | -4.47M | 3.15M | 2.60M | -3.18M | 2.77M | 1.68M | 2.54M | -11.27M | 4.12M | 4.02M | |||
| Financing Activities | ||||||||||||||||||||||
| Other financing activities | 0.17M | 0.21M | -0.00M | |||||||||||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||
| Long-Term Debt Issuances | 0.15M | 0.07M | 0.07M | 0.15M | 0.10M | 0.07M | 0.20M | 0.15M | 0.15M | 0.07M | 0.07M | 0.15M | 0.15M | 0.07M | 0.07M | 0.15M | 0.15M | 0.07M | ||||
| Change in Capital Stock | ||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.03M | 0.45M | 9.05M | 0.58M | 8.12M | 0.05M | 0.17M | 0.80M | ||||||||||||||
| Misc. | ||||||||||||||||||||||
| Cash from Financing Activities | -0.05M | 10.26M | -0.15M | -0.15M | 14.75M | -0.45M | 5.75M | -0.07M | -0.28M | -0.18M | 5.33M | -0.14M | -0.15M | 5.92M | 0.02M | -0.15M | -0.15M | 18.29M | 0.06M | -0.15M | ||
| Exchange Rate Effect | 454.00 | -423.00 | ||||||||||||||||||||
| Change in Cash | -1.07M | 6.83M | -2.29M | -2.50M | 2.56M | -2.39M | 0.51M | 1.39M | -1.60M | -0.76M | -0.57M | 1.01M | 0.27M | 0.51M | 0.20M | -2.15M | 0.16M | 1.99M | -0.69M | 0.72M | ||
| Free Cash Flow | -0.91M | -3.18M | -2.09M | -2.15M | -2.29M | -1.94M | -1.75M | -1.57M | -1.32M | -3.22M | -1.43M | -2.01M | -2.18M | -2.24M | -2.59M | -3.69M | -2.23M | -5.04M | -4.87M | -3.14M | ||
| Net Cash Flow | -1.07M | 6.83M | -2.29M | -2.50M | 2.56M | -2.39M | 0.51M | 1.39M | -1.60M | -0.76M | -0.57M | 1.01M | 0.27M | 0.51M | 0.20M | -2.15M | 0.16M | 1.99M | -0.69M | 0.72M |